Categories: All postsBlockchain

HIVE Blockchain’s future looks precarious, this analyst says

Investors interested in the cryptocurrency space need look no further than mining company HIVE Blockchain (HIVE Blockchain Stock Quote, Chart TSXV:HIVE) to get a glimpse at what falling prices for bitcoin and ethereum can do to a company in the space, says Horizons ETFs analyst Brooke Thackray, who cautions that with bitcoin edging close to a crucial $6,000 support level, heading any lower could spell big trouble for HIVE.

Bitcoin is about to celebrate a 10-year anniversary of sorts, as it was on October 31, 2008, that someone (or someones —the identity remains a mystery) by the name of Satoshi Nakamoto published the paper, “Bitcoin: A Peer-to-Peer Electronic Cash System” that jumpstarted the cryptographic process which resulted in bitcoin’s launch just a few months later.

But while bitcoin’s rise and fall over the past year and a half is well-known, what the future holds for it and its crypto-cousins is unclear. Ethereum, HIVE Blockchain’s central mining focus, recently experienced a hitch in its development, as the upgrade called Constantinople had to be delayed until January, 2019. Like bitcoin, ethereum has seen both tremendous highs and now humbling lows, with the currency now priced at $202.00, a low not seen since July, 2017. (All figures in US dollars unless noted otherwise.)

The downward plunge in cryptocurrency prices has clearly impacted the fortunes of mining companies like HIVE, says Thackray, who spoke to BNN Bloomberg.

HIVE Blockchain stock chart mirrors bitcoin chart

“If you take a look at the graph for HIVE you can see that it looks very similar to bitcoin,” he says. “On bitcoin’s [chart], it’s really what we call a descending triangle in technical terms: each of the highs is lower going all the way across and we’re at support at about US$6,000. If we do see it break below that support, we would see negative repercussions where it actually might go much lower than that. And that would reflect back onto HIVE as well.”

HIVE, which began trading in September, 2017, saw its share price rise from C$0.74 to as high as C$6.75 just two months later. The decline was almost as swift, however, with the stock currently trading at C$0.60.

HIVE last reported earnings on August 29, showing Q1/2019 income from currency mining of $10.6 million and an adjusted EBITDA of $3.5 million.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: hive
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

3 days ago

Is SNAP a buy right now?

He feels the company made forward progress in its recent quarterly results, but Roth MKM analyst Rohit Kulkarni wants to… [Read More]

3 days ago

Bombardier wins price target raise at Desjardins

Following the company's first quarter results, Desjardins analyst Benoit Poirier has raised his price target on Bombardier (Bombardier Stock Quote,… [Read More]

3 days ago

Rogers is an undervalued stock, RBC says

With the integration of Shaw Communications underway, RBC analyst Drew McReynolds says Rogers Communications (Rogers Communications Stock Quote, Chart, News,… [Read More]

4 days ago

Tornado Global Hydrovacs is still a double, Beacon says

Following fourth quarter results he describes as "stronger than expected", Beacon Securities analyst Russell Stanley has raised his price target… [Read More]

4 days ago

Sell your Molson Coors stock, Citi says

Ahead if its first quarter results, Citi analyst Filippo Falorni says there is not much to like about Molson Coors… [Read More]

5 days ago